BNP Paribas Financial Markets Cuts Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

BNP Paribas Financial Markets lessened its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 12.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 182,914 shares of the real estate investment trust's stock after selling 26,069 shares during the quarter. BNP Paribas Financial Markets owned about 0.08% of Sabra Health Care REIT worth $3,168,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in SBRA. Principal Financial Group Inc. raised its stake in Sabra Health Care REIT by 2.5% in the 4th quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust's stock valued at $382,940,000 after purchasing an additional 536,247 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Sabra Health Care REIT by 4.3% in the fourth quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust's stock worth $178,621,000 after buying an additional 426,074 shares in the last quarter. Geode Capital Management LLC grew its stake in Sabra Health Care REIT by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust's stock valued at $110,550,000 after acquiring an additional 86,727 shares in the last quarter. Northern Trust Corp raised its holdings in Sabra Health Care REIT by 27.7% in the 4th quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after acquiring an additional 905,466 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Sabra Health Care REIT by 13.0% in the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock worth $69,967,000 after purchasing an additional 463,601 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Trading Down 3.2%

NASDAQ:SBRA traded down $0.57 on Wednesday, reaching $17.50. The company's stock had a trading volume of 670,675 shares, compared to its average volume of 2,179,994. Sabra Health Care REIT, Inc. has a 12-month low of $13.87 and a 12-month high of $20.03. The stock has a 50 day moving average price of $17.54 and a 200 day moving average price of $17.41. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of 32.92, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. During the same period last year, the company earned $0.35 EPS. The company's quarterly revenue was up 10.1% on a year-over-year basis. On average, equities analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 30th. Stockholders of record on Friday, May 16th will be issued a $0.30 dividend. The ex-dividend date is Friday, May 16th. This represents a $1.20 annualized dividend and a dividend yield of 6.86%. Sabra Health Care REIT's dividend payout ratio is currently 203.39%.

Analyst Ratings Changes

A number of research firms have recently issued reports on SBRA. Truist Financial upped their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "hold" rating in a research report on Tuesday, March 18th. Scotiabank raised their target price on Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research note on Monday, May 12th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Sabra Health Care REIT currently has a consensus rating of "Moderate Buy" and an average target price of $19.50.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.